Ontario Drug Benefit Act, R.S.O. 1990, c. O.10

Section 17

Pharmaceutical products

Cite as Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, s. 17 · current to November 11, 2026 · consolidated from January 1, 2022 · read from e-Laws on November 17, 2026

The text

(1) This Act applies with necessary modifications in respect of designated pharmaceutical products and, for the purpose, a designated pharmaceutical product shall be deemed to be a listed drug product. R.S.O. 1990, c. O.10, s. 17 (1). (2) The executive officer has the authority to, (a) determine the conditions which must be met before a pharmaceutical product, including an extemporaneous preparation, is designated as a designated pharmaceutical product; and (b) determine the drug benefit price of a designated pharmaceutical product, including determining a formula by which the drug benefit price may be calculated. 2006, c. 14, s. 26. (3) Section 22 does not apply for the purposes of this section. 2006, c. 14, s. 26. (4) The executive officer shall publish, on the Ministry’s website and in any other format the executive officer considers appropriate, any conditions or formulas that the executive officer determines under subsection (2). 2006, c. 14, s. 26. (5) In the event of a conflict between what is posted on the Ministry’s website under subsection (4) and what is posted in another format, the Ministry’s website prevails. 2006, c. 14, s. 26.
Read the Ontario Drug Benefit Act on e-Laws ↗